| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| natriumceftizoxim 10 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| piperacillin 2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant antihemofilifaktorpreparat, 2 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX , 500 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely pegvisomant 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| natriumceftizoxim 500 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Liothyronine sodium 20 microgram powder for solution for injection ampule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX, 250 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cytarabin 100 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| värmebehandlat humant faktor IX-pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| natriumvalproat 500 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| kalciumleukovorin 50 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| natriumceftizoxim 2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| humant immunglobulin G 10 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| faktor VIII-fraktion med hög renhet, 350 IE, pulver till injektionvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant antihemofilifaktorpreparat, 500 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| somatropin (rbe) 5,3 milligram/patron, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| piperacillin 4 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant antihemofilifaktorpreparat, 1 000 IE pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| fosaprepitant 115 mg, pulver till injektionsvätska, lösning, injektionsflaska 10 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cefoperazonnatrium 2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant antihemofilifaktorpreparat, 250 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cefoperazonnatrium 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ethacrynate sodium 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant alfaglukosidas 50 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ceftriaxone (as ceftriaxone sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant antihemofilifaktorpreparat, 1 500 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cytarabin 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Botulism immunoglobulin 100 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| metohexitalnatrium 5 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cyklofosfamid (som cyklofosfamidmonohydrat) 1 gram/injektionsflaska, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| porcin faktor VIII, 700 IE, pulver och vätska till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| metylprednisolonnatriumsuccinat 125 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Fludarabine phosphate 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| sekretin 40 mikrogram, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| piperacillinnatrium 3 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ampicillin (as ampicillin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| krisantaspas 10 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Floxacillin (as floxacillin sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ampicillin (as ampicillin sodium) 1 g and sulbactam (as sulbactam sodium) 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| molgramostim 300 mikrogram, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Pentostatin 10 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| metylprednisolonnatriumsuccinat 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely ampicillin (as ampicillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| imipenem 750 mg + cilastatin 750 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| mezlocillinnatrium 4 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| natriumceftriaxon 10 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| mezlocillinnatrium 1 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ampicillin (as ampicillin sodium) 125 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| cefoperazonnatrium 10 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefpirome (as cefpirome sulfate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| metylprednisolonnatriumsuccinat 500 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| mezlocillinnatrium 3 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| mezlocillinnatrium 2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely oxacillin (as oxacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| faktor IX-koncentrat, 500 IE, pulver till injektionsvätska, lösning, flaska 10 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely doxycycline hyclate 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Oxacillin (as oxacillin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| urofollitropin 75 IE, pulver till injektionsvätska, ampull |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| tobramycin 1,2 g, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX, 1 000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Floxuridine 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Mitomycin 2 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Chloramphenicol (as chloramphenicol sodium succinate) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| doxycyklinhyklat 200 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| bendamustin 100 mg, pulver till injektionsvätska, flaska 20 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Molgramostim 400 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| humant immunglobulin mot hepatit B 1000 IE, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Pegvisomant 20 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Pegvisomant 15 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| metylprednisolonnatriumsuccinat 40 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ceftriaxone (as ceftriaxone sodium) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| vekuroniumbromid 4 mg, pulver till injektionsvätska, flaska |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Plicamycin 2.5 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ceftriaxone (as ceftriaxone sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|